Holy Smokes, if EMHTF gets a breakthrough on this then this company might spike to a 5 billion company overnight.
Our molecule, with its unique mechanism of action that affects the validated targets of these diseases, like MS, can potentially change the course of this disease or, ideally, possibly cure the disease.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.